U.K. Investor Group Petition: 3M Dropped The Ball On BacLite
This article was originally published in The Gray Sheet
Executive Summary
Over four years ago, 3M acquired U.K.-based startup Acolyte Biomedica and its BacLite technology to detect the antibiotic-resistant MRSA bacteria, with stated plans to conduct U.S. clinical trials and seek a 2008 U.S. market launch.